Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism ATPase inhibitors(ATPase inhibitors), P-CAB(Potassium-competitive acid blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20FN3O4S |
InChIKeyNVOIBVBRUBFZQC-UHFFFAOYSA-N |
CAS Registry1957202-37-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peptic Ulcer Hemorrhage | Phase 3 | China | 15 Nov 2023 | |
Peptic Ulcer Hemorrhage | Phase 3 | China | 15 Nov 2023 | |
Duodenal Ulcer | Phase 2 | China | 22 Jul 2022 | |
Duodenal Ulcer | Phase 2 | China | 22 Jul 2022 | |
Hemorrhage | Phase 2 | China | 22 Jul 2022 | |
Hemorrhage | Phase 2 | China | 22 Jul 2022 | |
Upper gastrointestinal hemorrhage | Phase 2 | China | 22 Jul 2022 | |
Upper gastrointestinal hemorrhage | Phase 2 | China | 22 Jul 2022 |
Not Applicable | Gastroesophageal Reflux First line | - | (qrvloqblxx): RR = 1.08 View more | Positive | 01 Jan 2021 | ||
Proton-Pump Inhibitors |